Can Adagio’s Adintrevimab Hold Up Against Omicron BA.2?

 
• By Alaric DeArment
Adagio announced Phase II/III data for adintrevimab in COVID-19 prevention and treatment • Source: Alamy

More from COVID-19

More from Scrip